- Home
- SBFM vs PMCB Comparison
SBFM vs PMCB Comparison
Compare SBFM & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- PMCB
- Stock Information
- Founded
- SBFM 2006
- PMCB 1996
- Country
- SBFM United States
- PMCB United States
- Employees
- SBFM N/A
- PMCB N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SBFM Health Care
- PMCB Health Care
- Exchange
- SBFM Nasdaq
- PMCB Nasdaq
- Market Cap
- SBFM 6.5M
- PMCB 5.8M
- IPO Year
- SBFM N/A
- PMCB N/A
- Fundamental
- Price
- SBFM $1.49
- PMCB $0.90
- Analyst Decision
- SBFM Strong Buy
- PMCB
- Analyst Count
- SBFM 1
- PMCB 0
- Target Price
- SBFM $15.00
- PMCB N/A
- AVG Volume (30 Days)
- SBFM 54.6K
- PMCB 38.8K
- Earning Date
- SBFM 08-12-2025
- PMCB 08-11-2025
- Dividend Yield
- SBFM N/A
- PMCB N/A
- EPS Growth
- SBFM N/A
- PMCB N/A
- EPS
- SBFM N/A
- PMCB 3.19
- Revenue
- SBFM $36,341,741.00
- PMCB N/A
- Revenue This Year
- SBFM $32.20
- PMCB N/A
- Revenue Next Year
- SBFM $32.74
- PMCB N/A
- P/E Ratio
- SBFM N/A
- PMCB $0.28
- Revenue Growth
- SBFM 19.22
- PMCB N/A
- 52 Week Low
- SBFM $1.17
- PMCB $0.80
- 52 Week High
- SBFM $3.90
- PMCB $2.42
- Technical
- Relative Strength Index (RSI)
- SBFM 51.16
- PMCB 41.85
- Support Level
- SBFM $1.35
- PMCB $0.84
- Resistance Level
- SBFM $1.52
- PMCB $0.95
- Average True Range (ATR)
- SBFM 0.08
- PMCB 0.07
- MACD
- SBFM 0.01
- PMCB -0.00
- Stochastic Oscillator
- SBFM 66.30
- PMCB 39.96
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.